Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Quintiles To Expand in China | Contract Pharma

What are you searching for?

Sign in
Breaking News

Quintiles To Expand in China

HQ set for Shanghai, JV to add lab testing services

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Quintiles will establish regional headquarters for China in Shanghai. The company will also significantly its expand lab testing capabilities in China through a joint venture with Shanghai Clinical Research Centre (SCRC).

“With its burgeoning economy and growing healthcare needs for its 1.3 billion citizens, China exemplifies the opportunities and challenges of the New Health,” said Quintiles executive chairman Dennis Gillings, CBE. “By broadening our investment and infrastructure here, Quintiles is ready to partner with our biopharma customers as they look to realize China’s potential.”

To provide the infrastructure essential for its growth strategy in China, Quintiles is investing $14 million to establish a new 43,000-sq.-ft. HQ in Shanghai to serve China and nearby Asian countries. The office in Feng Lin Science Park is designed to achieve LEED Gold accreditation; it is expected to accommodate more than 450 employees in the next five years.

“These investments and agreements demonstrate our commitment to this District and to China,” said Ling Zhen, general manager for Quintiles’ operations in China. “Quintiles recognizes the unique needs of our customers in China. By collaborating with SCRC in labs we can help local and international biopharma companies develop new and better medicines to serve China’s enormous unmet medical needs.”

The Quintiles-SCRC collaboration follows last year’s launch of Kun Tuo, Quintiles’ local contract research organization, built to help local and global biopharma companies achieve successful registration of medicines in China. Quintiles commenced operations in China in 1997, and today has existing offices in Beijing, Dalian, Hong Kong and Shanghai, with employees and capabilities to serve all major population centers and study sites across China.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics